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Abstract
The rat is a commonly used model for immunological investigation. Yet basic research and
characterisation of leukocyte populations and sub-sets lags far behind murine research, with
inconsistency on reported leukocyte markers and their overlap. These shortcomings limit the
opportunity for more complex and advanced rat immunology research. In this study, we devel-
oped a robust 9-colour flow-cytometric protocol to elucidate the major blood and tissue rat leu-
kocyte populations, and validated it in a model of LPS-induced pulmonary inflammation.
Blood and tissues (lung, BALF, spleen, liver, bonemarrow) from naïve Sprague-Dawley rats
were collected and analysed by flow cytometry (FCM). Rats were exposed to aerosolised
saline or LPS (1mg/mL), at 3 and 24hrs thereafter blood, lung and BALF were collected and
analysed using FCM and ELISA. Neutrophils, two monocyte subsets, NK Cells, B Cells,
CD4+, CD8+ T Cells and alveolar macrophages can be identified simultaneously across dif-
ferent tissues using a 9-colour panel. Neutrophils and monocytes can be distinguished based
upon differential expression of CD43 and His48. Neutrophils and CD43Lo/His48Hi monocyte-
macrophages are elevated in the lung at 3 and 24hrs during LPS-induced pulmonary inflam-
mation. This validated method for leukocyte enumeration will offer a platform for greater con-
sistency in future rat immunology and inflammation research.
Introduction
Reproducible and robust characterisation of leukocytes is necessary for advanced immunological
and inflammation research. Studies conducted in rat are currently limited by the lack of an accu-
rate and validated method that permits simultaneous quantification of major leukocyte subsets.
Neutrophils are the primary first responder to inflammation [1]. Following release from the
bone marrow these cells are capable of circulating in the periphery [2], marginating in the
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vasculature or being recruited into tissues through a complex chemokine and cytokine cascade
facilitated by endothelial and epithelial cells [2]. In the rat they are commonly distinguished by
expression of the RP-1 antigen [3] or His48 together with high-granularity [4].
Monocytes are another early responder to sites of local and systemic inflammatory
responses [5]. Two circulating subsets are observed in humans and rodents [6]. In humans
these are characterised by differential CD14 and CD16 expression [7], in mice by CCR2,
CX3CR1 and Ly6C [8,9] and in rats by CD43 expression [10]. In rats, CD43 Hi and Lo mono-
cytes are thought to be analogous to the Ly6C Lo (Non-classical) and Hi (Classical) murine
monocytes respectively [11,12]. Macrophages play key roles in tissue homeostasis and inflam-
mation. Believed to originate from embryonic progenitors, they possess the ability for self-
renewal, thus enabling maintenance of the macrophage pool in adulthood [5]. In rats, CD68
(ED1) is considered to be a ‘pan-macrophage’marker [13].
Natural Killer (NK) cells are responsible for surveying and responding to stressed or abnor-
mal tissue and are capable of activating or supressing inflammatory responses by interacting
with macrophages, T Cells and Dendritic Cells (DCs) [14]. In the rat they are recognised by
CD161 (NKR-P1) [4]. T Cells and B Cells play key roles in anti-viral, bacterial and cancer
responses. T Cells are commonly distinguished by either their CD3 or T Cell Receptor (TCR)
expression, with co-expression of CD4 or CD8 characterising ‘helper’ and ‘cytotoxic’ sub-pop-
ulations respectively, or Foxp3 and CD25 for ‘regulatory’ T Cells [15]. B Cells are identified by
expression of CD45RA [16], a uniquely expressed isoform of the common leukocyte antigen.
However, limitations in the availability of antibodies and choice of different fluorochromes
means investigators must either perform costly repeated staining and analysis for different
populations or attempt to elucidate multiple populations with few markers; compromising the
accuracy of findings. The aim of this study was to develop a simple and reproducible method
to simultaneously examine rat leukocyte populations across different tissues by flow cytometry
(FCM). We then validated this method in a well-characterised model of Lipopolysaccharide
(LPS) induced pulmonary inflammation.
Methods
Animals and ethics
Sprague-Dawley female rats (180–200g) were purchased from Charles River (Kent, UK). Food
and water were supplied ad libitum. Guidelines for animal welfare were strictly observed under
the Scientific Procedures Act 1986 Home Office, United Kingdom. Euthanasia was performed
under license either by overdose intraperitoneal injection of pentobarbitone or overdose of
CO2 inhalation. This study was conducted under Home Office Institutional and departmental
License for which full ethical approval is granted.
LPS aerosolised inhalation
Rats were simultaneously exposed in separate chambers to aerosolised LPS (Sigma-Aldrich,
USA) 1mg/ml or sterile saline (Fresenius Kabi, UK) for 30 minutes. At 3 and 24hrs thereafter,
rats were euthanised by anaesthetic overdose of intra-peritoneally (i.p) injected Pentobarbi-
tone. Naïve rats used in this study were euthanised by overdose of CO2 inhalation.
Tissue collection
Unless otherwise stated, centrifugations were performed at 4°C and media used throughout
was RPMI (Sigma-Aldrich) containing 10% Fetal Bovine Serum (FBS) (Invitrogen, USA). After
overdose, blood was collected in citrated tubes on ice from the right femoral vein and
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centrifuged at 1300g for 10 mins. Plasma was collected and stored at -80°C for further analysis.
Lungs were lavaged twice using 3mL of ice-cold RPMI each with a 30 second pause before col-
lection. Broncho-alveolar lavage fluid (BALF) was centrifuged at 800g for 5 mins, supernatant
was stored at -80°C and cells were resuspended on ice. For FCM, right inferior lung lobes, supe-
rior caudate liver lobes and spleen were collected in media on ice. Bone marrow was flushed
from the left tibia using media, cells were centrifuged at 800g and resuspended on ice.
Tissue processing
Lung and liver lobes were cut by scissor into smaller fragments and suspended in media con-
taining tissue digestion enzymes; DNAse I 5mg/mL, Collagenase D 30mg/mL and Dispase II
5mg/mL (all from Roche, Switzerland). Tissue was incubated in digestion buffer in a water
bath with shaking at 37°C for 30 minutes. After, liver cells were resuspended in 36% Percoll
(Sigma-Aldrich) (adapted from [17]) and centrifuged for 10mins at 500g without brake to sep-
arate leukocytes from fibrous tissue. Spleen was cut into smaller fragments but not subjected to
enzymatic digestion. All tissues were strained using a 40μM nylon mesh (Fisher Scientific,
USA). Red blood cells were lysed using Ammonium-Chloride-Potassium buffer as previously
described [18]. Cell pellets were resuspended and viable cells counted using Trypan blue stain-
ing solution on a haemocytometer (Nikon, Tokyo Japan). Cytospins were performed on glass
covered slips stained with Wright-Geimsa stain (Sigma-Aldrich) and imaged using a light
microscope (Leica, Germany).
Flow cytometry
Four lasers and 9 different PMT channels were utilised for the 9-colour staining panel; cells
were stained with antibodies as detailed in Table 1. Briefly, cells were washed and stained with
Live/Dead dye (eBioscience) in PBS. Cells were blocked with anti-CD32 to prevent Fc-medi-
ated non-specific binding as per manufacturer’s instructions. Cells were then stained with anti-
bodies in buffer containing PBS, 1% Bovine Serum Albumin (BSA) and 0.1% Sodium Azide at
4°C for 30 mins followed by further washing and cell fixation (BD Cell Fix). For monocyte sur-
face antigen characterisation, cells were stained with the baseline antibodies detailed in Table 2.
Cells were then stained with all antibodies listed in Panel 1 and each sample individually with a
Mab listed in Panel 2. Flow cytometric compensation was performed using fluorescent com-
pensation beads (OneComp eBeads, eBioscience USA) and cells were analysed using a multi-
parameter flow cytometer (Fortessa LSR BD Biosciences, USA). Cell sorting was performed
using a Fortessa Aria (BD Biosciences, USA). For identification of positive and negative
Table 1. Monoclonal antibodies for general leukocyte FCM.
Antibody Fluorochrome Supplier Clone Dilution Laser Filter
Live-Dead eFluor1 780 eBioscience 1 in 1000 Red (640nm) 780/60
CD32 N/A BDPharmingen D34-485 1 in 200
CD45 Alexa-Fluor1 700 Biolegend OX-1 1 in 100 Red (640nm) 730/45
CD3 VioGreen Miltenyi Biotec REA223 1 in 100 Violet (405nm) 525/50
CD4 V450 BDBioscience OX-35 1 in 200 Violet (405nm) 450/50
CD8 PerCP-eFluor1 710 eBioscience OX8 1 in 200 Blue (488nm) 695/40
CD43 PE Biolegend W3/13 1 in 200 Yellow-Green (561nm) 585/15
His48 FITC eBioscience HIS48 1 in 200 Blue (488nm) 530/30
CD161 APC Biolegend 3.2.3 1 in 200 Red (640nm) 670/14
CD45R (B220) PE-Cy7 eBioscience HIS24 1 in 200 Yellow-Green (561nm) 780/60
doi:10.1371/journal.pone.0142520.t001
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populations, the fluorescence minus one (“FMO”) principle was utilised to account for back-
ground antibody fluorescence.
ELISA
BALF was thawed and analysed using a multiplex ELISA (MesoScaleDiscovery Maryland,
USA) according to the manufacturer’s instructions.
Data & Statistics
All data were collected from 2–3 individual experiments expressed as mean ± standard error of
mean (SEM). Flow cytometric data were analysed using FlowJo v7.6.5 (Tree Star Inc, USA).
Statistical data analysed using a non-parametric Mann Whitney t-test using GraphPad Prism
v5 (San Diego, USA), p<0.05, p<0.01.
Results
Leukocyte panel and distribution
Using antibodies targeted against a range of surface antigens (Table 1A) our gating strategy in
blood (Fig 1A) first removed debris (i) and cells that were not: ‘live’ (ii), singlets (iii) or CD45+
(iv). To remove singlets, we utilised the FSC-H and FSC-W parameters to identify and exclude
cells stuck together (doublets) and larger clumps. This resulted in a population of live single
leukocytes which were then sequentially separated, first for T lymphocytes by CD3 (v) which
were further delineated by CD4 and CD8 (vi). NK cells were identified by CD161 (vii) and B
Cells by CD45R (viii). We took advantage of the differential expression of CD43 and higher
granularity of neutrophils (ix) to separate them from two monocyte subsets (CD43Lo/His48Hi
and CD43Hi/His48Int-Lo) which demonstrated reciprocal expression for CD43 and His48 (x).
The same gating strategy was applied successfully to lung tissue (Fig 1B i-x), we were able to
identify Alveolar Macrophages based on their unique pattern of autofluorescence. Fig 1C
shows the relative distribution of back-gated cell populations in lung tissue (i,ii) according to
CD43 and His48 expression, and their respective distribution in BALF (iii), liver (iv), spleen (v)
and bone marrow (vi). To validate the specificity of our panel, we sorted neutrophils,
Table 2. Monoclonal antibodies for monocyte surface antigen characterisation.
Antibody Fluorochrome Supplier Clone Dilution
Baseline Mabs
Live-Dead eFluor1 780 eBioscience 1 in 1000
CD32 N/A BDPharmingen D34-485 1 in 200
CD3 VioGreen Miltenyi Biotec REA223 1 in 100
CD43 PE Biolegend W3/13 1 in 200
His48 FITC eBioscience HIS48 1 in 200
Panel 1
MHCII PerCP-eFluor1 710 eBioscience OX17 1 in 200
CD11b V450 BDBioscience WT.5 1 in 200
CD172a Alexa-Fluor1 700 Novus Biologicals OX-41 1 in 50
Panel 2
CD163 Alexa Fluor1 647 Serotec ED-2 1 in 50
CD86 Alexa Fluor1 647 Biolegend 24F 1 in 50
CD11c Alexa Fluor1 647 Serotec 8A2 1 in 50
doi:10.1371/journal.pone.0142520.t002
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Fig 1. A 9-colour flow cytometric panel of major leukocyte subset discrimination in the rat.Rat blood (A) and lung tissue (B) were collected and
processed for FCM staining with antibodies listed in Table 1. Cells from the lung were then back-gated to show cellular profiles according to specific antibody
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monocytes, lymphocytes and NK cells from the blood and AlvMacs from the lung, before
preparation as cytospins for morphological examination by light microscopy using Geimsa
staining (Fig 1D). All cells demonstrated the typical morphology expected. We noted that
CD43Lo/His48Hi monocytes appeared to show ‘kidney-bean’ shaped nuclei, compared to
CD43Hi/His48Int-Lo which exhibited a larger more spherical nuclei. Finally, we compared the
relative proportion of cells recognised in our FCM panel in naïve rats (Fig 1E) as a percentage
of CD45+ cells. We did not examine cell populations in the BAL due to the over-abundance of
alveolar macrophages in naïve rats.
Monocyte characterisation
Monocyte populations were further characterised using antibodies detailed in Table 2. We
show (Fig 1A) that His48 is an additional marker that exhibits reciprocal expression to CD43
on monocytes. Fig 2A shows an increased granularity (SSC-A) of CD43Lo/His48 Hi monocytes
compared to CD43Hi/His48Int-Lo, but these monocytes are still less granular than neutro-
phils. CD43Hi/His48Int-Lo monocytes are uniformly CD4 positive, with 68%±2 of cells posi-
tive for CD161. Conversely, 71%±7 of CD43Lo/His48Hi monocytes were CD4 negative, 98%
were CD161 positive (Fig 2B). We then examined the expression of each monocyte subset for
CD11c, MHCII, CD11b, CD172a, CD163, and CD86 (Fig 2C). We found CD43Hi/His48Int-
Lo monocytes were CD11c positive and MHC II negative, while CD43Lo/His48Hi monocytes
were CD11c negative and MHC II positive. Both monocyte subsets were uniformly positive for
CD11b, CD172a and CD86 and negative for CD163. Taken together our data show that a FCM
strategy using CD43 in combination with His48 can effectively distinguish two-distinct popula-
tions of monocytes, and be utilised to discriminate major leukocyte populations across blood
and tissue.
LPSModel
We utilised our 9-colour FCM panel to investigate changes in blood leukocytes after adminis-
tration of aerosolised LPS to rats (Fig 3). At 3hrs, blood neutrophils were over three-fold
higher (Saline: 0.99E5±0.19 LPS:3.6E5±0.64E5 cells/mL, p<0.01) and remained elevated
(Saline: 1.37E5±0.56E5 LPS:2.4E5±0.56E5 cells/mL, p>0.05) at 24hrs. We saw an increase in
CD43Lo/His48Hi monocytes in the blood at 3hrs (Saline: 0.07E5±0.02E5 cells/mL LPS:0.24E5±
0.06E5 cells/mL p = 0.055), but no significant differences amongst CD43Hi/His48Lo-Int
monocytes, NK, B or T Cells in the blood at either time point. In the BALF, we saw a significant
and selective increase in the total number of neutrophils at 3hrs (Saline: 0.39E5±0.23E5
LPS:33.4E5±9.45E5 cells, p<0.01) and 24hrs (0.14E5±0.19E5 LPS:4.40E5±1.99E5 cells,
p<0.05) as confirmed by FCM and cytospins (Fig 4A), together with significant increases in
total lung neutrophils at 3hrs (Saline: 18.4E5±6.21E5 LPS:93.0E5±11E5 cells, p<0.01) and
24hrs (Saline: 8.7E5±2.1E5 LPS:71.7E5±14.9E5 cells, p<0.05) (Fig 4B). We observed signifi-
cantly increased levels of CD43Lo/His48Hi monocyte-macrophages in the lung at 3hrs
(Saline:11E5±2.69E5 LPS:23.9E5±5.50E5 cells, p<0.05) and 24hrs (Saline: 4.18E5±0.54E5
LPS:30.5E5±3.07E5 cells, p<0.01) but no significant changes in the CD43Hi/His48Int-Lo sub-
set at either time point (Fig 4C). We saw no other significant differences in NK, B or T Cells or
alveolar macrophages (Fig 4D). We then examined pro-inflammatory cytokine release in the
expression presented using CD43 and His48 expression, together with the corresponding distribution profiles for BALF, liver, spleen and bone marrow (C).
Leukocytes from the blood and AlvMacs from the lung were then sorted and images of cytospins stained with wright-geimsa were obtained (D). Blood, lung,
liver, spleen and bone marrow were processed, analysed and the relative proportion of each leukocyte population presented (E) where n = 3 naïve rats from
a single experiment presented mean ± SEM.
doi:10.1371/journal.pone.0142520.g001
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BALF; 3hrs after challenge significant increases were seen in CXCL-1 (Saline:4.27±3.05
LPS:1517±914pg/mL, p<0.05) and IL-6 (Saline:4.27±3.05 LPS:1517±914pg/mL, p<0.05) with
marked increases in IL-1b (Saline:5.15±4.76 LPS:224±26.2pg/mL, p = 0.057) and TNF-α
(Saline:2.74±0.47 LPS:1912±893pg/mL, p = 0.057) (Fig 5).
Fig 2. Rat monocyte subsets differ in granularity and cell-surface antigen expression. ‘CD43lo-His48Hi’ and ‘CD43Hi-His48Int-Lo’ blood monocytes
and neutrophils were analysed by FCM for granularity by mean side-scatter (A). CD4 and CD161 expression was examined by FCM, with gates drawn
according to FMO’s, quadrants presented as mean ± SEM from 3 rats (B). Surface expression of CD11c, MHC II, CD11b, CD172a, CD163 and CD86 were
determined in relation to FMO’s by FCM, histograms are representative. Red histograms show the gated population’s FMO, blue histograms show the gated
population’s fluorescence (C).
doi:10.1371/journal.pone.0142520.g002
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Discussion
Gating strategy
A 9 colour FCM antibody panel has been validated for use in the rat to simultaneously study all
major leukocyte populations including neutrophils, B, NK, CD4+ and CD8+ T Cells, AlvMacs
and two distinct subsets of monocytes across several tissues. This study is the first to utilise the
differential expression of CD43 [10] and His48 on cells to facilitate the delineation of 7 major
Fig 3. Changes in circulating leukocytes after aerosolised LPS challenge.Rats were exposed to 30mins of aerosolised LPS or saline, at the designated
time point blood was collected, processed and analysed. Data are n = 5–6 from 2–3 independent experiments, presented as mean ± SEMwhere *p<0.05,
**p<0.01.
doi:10.1371/journal.pone.0142520.g003
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leukocyte populations across tissues (Fig 1A, 1B and 1C). To our knowledge, no other reported
combination of two antibodies permits this in the rat. CD43 is known to play roles in leukocyte
tissue emigration and endothelial cell adhesion [19], with reduced expression on neutrophils
associated with cellular activation [20]. The functional properties of His48 are less well under-
stood, however it is frequently used as a granulocyte marker [21,22]. We were able to identify
Fig 4. Lung Neutrophils and CD43Lo/His48Hi monocyte-macrophages selectively respond to LPS challenge. BALF (A) and lung (B, C, D) were
collected, processed and analysed by FCM at 3 and 24hrs. Data are n = 5–6 from 2–3 independent experiments, presented as mean ± SEMwhere *p<0.05,
**p<0.01.
doi:10.1371/journal.pone.0142520.g004
Fig 5. Early pro-inflammatory cytokine release in the BALF following LPS challenge. Increases in pro-inflammatory cytokines were measured in the
BAL using an MSDmultiplex ELISA according to manufacturer’s instructions. Data are n = 3–4 from 2–3 independent experiments performed in single
determinations presented as mean ± SEMwhere *p<0.05, **p<0.01.
doi:10.1371/journal.pone.0142520.g005
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Alveolar Macrophages based on their unique pattern of autofluorescence and then confirmed
the validity of our gating strategy and panel by sorting and examining cellular morphology (Fig
1D). As shown in Fig 1E our single panel captures the vast majority of CD45+ cells, which in
the blood—as expected in the laboratory rat—lymphocytes predominate. This panel could aid
rat immunology investigators by serving as a standard for rat leukocyte surface markers in the
literature, thereby promoting research consistency; and through economical identification of
leukocyte subsets using only 2 or 3 antibodies from this panel, providing greater opportunity to
interrogate cell subsets with the remaining PMT channels/antibodies available to investigators.
Monocyte Characterisation
Monocytes are recruited to and participate in local and systemic inflammatory responses. Two
circulating subsets exist in rats and are typically differentiated by CD43 expression alone [10]
or with CD172a (SIRP alpha) [23,24]. Despite the growing consensus amongst monocyte
investigators in the human and murine literature, this is the first rat study to incorporate
monocyte subset delineation into a panel that captures 5 other leukocytes, and demonstrates
their distribution across a range of tissues.
Rat monocytes (without sub-set discrimination) have previously been described as ‘SSClow
CD4dim’ [4] or ‘CD172a+ TCR-’ [15] by FCM, and by immunohistochemistry using CD68
and CD11b [25] or CD172a alone [26]. CD43Hi monocytes have also previously been shown
to be CX3CR1+ CD11c+ and CCR2–, whilst CD43Lo monocytes are CX3CR1lowCD11c– but
were CCR2+ [27]. We found each monocyte subset exhibited reciprocal (Figs 1 and 2) expres-
sion of CD43 and His48. His48 expression on rat monocytes thus appears analogous to that of
Ly6C on murine monocytes [6,11,12].
We characterised the two monocyte populations for common markers (Fig 2B and 2C).
CD4 and CD161 are two particular antigens known to decrease and increase in expression
respectively during monocyte activation [28], however our data suggest rat monocytes are not
CD4 ‘dim’ as described elsewhere [4]. As shown in Fig 2C we found CD43Hi/His48Int-Lo
monocytes were CD11c positive and MHC II negative, conversely CD43Lo/His48Hi mono-
cytes were CD11c negative and MHC II positive. Both monocyte subsets were uniformly posi-
tive for CD11b, CD172a and CD86 and negative for CD163 as reported elsewhere [23,27,29].
Further, we saw both CD43Hi/His48Int-Lo and CD43Lo/His48Hi monocyte populations dis-
tributed across rat tissues (Fig 1C and 1D), particularly in the lung. Due to a lack of firm data
regarding these tissue populations, we termed them ‘Monocyte-macrophages’ as reported pre-
viously [30–33]. Thus, taken together our data on monocytes aligns with the literature that sug-
gests CD43Lo rat monocytes are analogous to Ly6CHi murine monocytes with the capacity to
participate in acute inflammatory responses: a view supported by previous studies in the rat
[34,35]. Indeed, CD43Lo monocytes have also been shown in higher numbers at later time
points in a model of lung allograft rejection [36] and were isolated directly from the pulmonary
vasculature. This highlights the potential for these cells to participate in the inflammatory
response from the luminal side of the alveolar-capillary boundary, as well as from within the
parenchyma during inflammatory responses.
LPS Pulmonary Inflammation
To validate our FCM panel and examine monocyte-macrophage specific changes, we used an
established aerosolised rat LPS model [37] to investigate cellular inflammation at 3 and 24hrs
post-challenge. The leukocyte response to pulmonary inflammation is elicited by the activation
of airway tissue pattern recognition receptors. Toll-like receptors (TLR) 2 and 4 are ligated by
LPS and evoke signalling that stimulates the release of pro-inflammatory cytokines such as
Major Rat Leukocyte Populations: LPS Validation
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TNF-α and IL-1b from airway tissues, including alveolar macrophages and epithelial cells. This
enables leukocyte recruitment by increasing membrane permeability, stimulating chemokine
production from endothelial and epithelial cells and promoting upregulation of adhesion mole-
cules on endothelial and immune cells thereby coordinating leukocyte recruitment.
In the rat, this response is well characterised, with neutrophil recruitment seen in airways
from as early as 2hrs post-challenge, peaking at 12hrs before beginning to subside by 24hrs,
together with significant increases in lung neutrophils [37]. Accordingly, we saw a significant
neutrophil specific increase in the blood at 3hrs (Fig 3) with marked increases in CD43Lo/
His48Hi monocytes, both of which had diminished by 24hrs. No changes were seen in any
other cell types between saline and LPS groups at either time point (Fig 3). As reported previ-
ously [37], we saw substantial neutrophil recruitment into the BAL at 3hrs which had subsided
by 24hrs (Fig 4A) confirmed both by FCM and cytospins (Fig 4A); together with significant
increases in neutrophils in the lung by FCM (Fig 4B).
But interestingly–to our knowledge for the first time in the rat—significant increases at both
time points were seen in CD43Lo/His48Hi monocyte-macrophages but not CD43Hi/His48Int-
Lo monocyte-macrophages (Fig 4B and 4C). Monocytes are known to respond directly to LPS
via the p38 MAPK pathway [38] releasing pro-inflammatory cytokines [37]. Studies show
monocytes can infiltrate lung tissue after LPS challenge using both CD11/CD18 and VLA-4
dependant and independent pathways [39], where they may also influence neutrophil lung
trafficking [35]. Their depletion prior to LPS exposure can diminish the neutrophil response in
a murine model [35] suggesting a key monocyte role in influencing neutrophil-mediated dam-
age in LPS-induced pulmonary inflammation [40]. Taken together, this study presents new
insights into the selective role of rat monocyte-macrophages in LPS pulmonary inflammation.
Study Significance
This study provides a framework for consensus in the rat literature regarding leukocyte identi-
fication. It highlights the utility of CD43 and His48 as two versatile markers, including in dis-
criminating neutrophils and CD43Hi and Lo monocytes; and demonstrates the latter’s hitherto
unreported selective response to LPS pulmonary inflammation. With other organs, such as the
spleen, increasingly recognised as major immunological sites capable of giving rise directly to
immune cells such as monocyte-macrophages that participate in distal inflammatory responses
[41,42]; this panel holds the potential to advance understanding of splenic and hepatic immune
contributions in rat models of disease. Finally, with further research, this panel could be
expanded to encapsulate new cells and subsets as they arise.
Conclusion
In this study we have developed a 9 colour FCM panel to enable the efficient identification and
quantification of all major rat leukocyte subsets including classical and non-classical mono-
cytes and monocyte-macrophages. We validated this panel in an LPS model of pulmonary
inflammation and demonstrate the selective response not only of neutrophils but also
CD43Lo/His48Hi monocyte-macrophages to LPS in a rat pulmonary inflammation model.
These monocyte-macrophages were significantly elevated in the lungs at 3 and 24hrs, and may
play a role influencing the neutrophil response and onward resolution of inflammation.
Supporting Information
S1 Supporting Information. Minimal data set for Figs 3–5. Data are contained in spread-
sheet format according to figures.
(XLSX)
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